KIMS vs SHALBY: Stock Comparison

Krishna Institute of Medical Sciences Limited vs Shalby Limited

Live data: 6 August 2026, 4:08 PM IST • Source: NSE and company filings

Krishna Institute of Medical Sciences Limited is the larger company by market capitalisation. Krishna Institute of Medical Sciences Limited shows a higher ROE, faster revenue growth and a higher ROCE, while Shalby Limited shows a lower P/E and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Krishna Institute of Medical Sciences Limited and Shalby Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, KIMS is more favourable on 7 of 13 scored metrics and SHALBY on 5These counts are context-free and are not an overall rating.

Key Differences

Market Cap
KIMS is the larger company
₹33,972 Cr vs ₹1,747 Cr
P/E Ratio
SHALBY has a lower P/E
46.82x vs 158.32x
P/B Ratio
SHALBY has a lower P/B
1.74x vs 14.26x
EPS
KIMS has higher earnings per share
₹6.04 vs ₹3.23
Revenue Growth (TTM YoY)
KIMS has faster revenue growth
34.8% vs 8.5%
EPS Growth (TTM YoY)
SHALBY has faster EPS growth
0% vs -58.3%
Qtr Sales Growth
KIMS has stronger quarterly sales growth
34.8% vs 8.52%
Qtr Profit Growth
SHALBY has stronger quarterly profit growth
266% vs -50.7%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKIMSSHALBY
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricKIMSSHALBY
Live Price₹808.6₹162.16
Day Change0.8%-0.07%
Volume5.04 L1.33 L
52-Week High₹858₹274.7
52-Week Low₹575.8₹125.82
Distance from 52W High-5.76%-40.97%

Valuation

MetricKIMSSHALBY
Market Cap₹33,972 Cr₹1,747 Cr
P/E Ratio158.32x46.82x
P/B Ratio14.26x1.74x
EPS₹6.04₹3.23
Book Value₹56.17₹94.39
Dividend Yield0%0%

Growth

MetricKIMSSHALBY
Revenue Growth (TTM YoY)34.8%8.5%
EPS Growth (TTM YoY)-58.3%0%
Qtr Sales Growth34.8%8.52%
Qtr Profit Growth-50.7%266%

Profitability & Leverage

MetricKIMSSHALBY
ROE11.3%3.74%
ROCE9.29%6.48%
Net Margin6.18%3.28%
Operating Margin20.5%12.5%
Debt to Equity1.89x0.59x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKIMSSHALBY
Promoter Holding32.5% 1.61 pp74.33%
FII Holding14.74% 0.17 pp4.46% 0.1 pp
DII Holding34.43% 1.93 pp0.3% 0.05 pp
Public Holding18.33% 0.49 pp20.26% 0.15 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Krishna Institute of Medical Sciences Limited and Shalby Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.